- Home
- ENTA vs FREY Comparison
ENTA vs FREY Comparison
Compare ENTA & FREY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- FREY
- Stock Information
- Founded
- ENTA 1995
- FREY 2018
- Country
- ENTA United States
- FREY Luxembourg
- Employees
- ENTA N/A
- FREY N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- FREY Industrial Machinery/Components
- Sector
- ENTA Health Care
- FREY Miscellaneous
- Exchange
- ENTA Nasdaq
- FREY Nasdaq
- Market Cap
- ENTA 245.4M
- FREY 293.4M
- IPO Year
- ENTA 2013
- FREY N/A
- Fundamental
- Price
- ENTA $9.31
- FREY $2.54
- Analyst Decision
- ENTA Buy
- FREY
- Analyst Count
- ENTA 3
- FREY 0
- Target Price
- ENTA $19.67
- FREY N/A
- AVG Volume (30 Days)
- ENTA 114.1K
- FREY 6.3M
- Earning Date
- ENTA 11-25-2024
- FREY 11-06-2024
- Dividend Yield
- ENTA N/A
- FREY N/A
- EPS Growth
- ENTA N/A
- FREY N/A
- EPS
- ENTA N/A
- FREY N/A
- Revenue
- ENTA $71,960,000.00
- FREY N/A
- Revenue This Year
- ENTA N/A
- FREY N/A
- Revenue Next Year
- ENTA $5.14
- FREY $414.23
- P/E Ratio
- ENTA N/A
- FREY N/A
- Revenue Growth
- ENTA N/A
- FREY N/A
- 52 Week Low
- ENTA $8.51
- FREY $0.91
- 52 Week High
- ENTA $17.80
- FREY $2.85
- Technical
- Relative Strength Index (RSI)
- ENTA 28.86
- FREY 66.18
- Support Level
- ENTA $10.84
- FREY $2.07
- Resistance Level
- ENTA $10.89
- FREY $2.40
- Average True Range (ATR)
- ENTA 0.49
- FREY 0.29
- MACD
- ENTA -0.19
- FREY 0.04
- Stochastic Oscillator
- ENTA 18.18
- FREY 86.06
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About FREY FREYR Battery Inc.
FREYR Battery Inc is an emerging producer of clean battery solutions for the planet. It designs and manufactures high-density and cost-competitive lithium-ion batteries with a reduced carbon footprint for the markets for electric mobility, stationary energy storage, and marine and aviation applications.